Beijing Yingu Century Pharmaceutical

Beijing Yingu Century Pharmaceutical is a China-based pharmaceutical company focused on the research, development, and commercialization of innovative and high-end generic drugs. The company specializes in therapeutic areas such as oncology supportive care, respiratory diseases, and allergic conditions. Its flagship products include Aprepitant and Fosaprepitant Dimeglumine, which are used to manage chemotherapy-induced nausea and vomiting (CINV). Yingu Century maintains a robust R&D infrastructure in Beijing and has successfully transitioned from a technology-driven firm to a fully integrated pharmaceutical enterprise with manufacturing and sales capabilities. The company is recognized for its Class 1 innovative drug candidates and its commitment to improving patient access to critical therapies in the Chinese market.